
Peter Palese, PhD
About Me
http://labs.icahn.mssm.edu/paleselab/
Wikipedia
Visit Dr. Palese's Wikipedia page
Video
Watch a video featuring the Microbiology and Virology Ph.D. Graduate School Program.
Language
Position
Research Topics
Antivirals, Apoptosis/Cell Death, Biodefense, Coronavirus, Influenza Virus, Interferon, Interferon Antagonists, Nipah Virus, Paramyxovirus, RNA, SARS Virus, Vaccine Development, Virulence Genes, Viruses and Virology
Multi-Disciplinary Training Areas
Disease Mechanisms and Therapeutics (DMT), Microbiology [MIC]
About Me
http://labs.icahn.mssm.edu/paleselab/
Wikipedia
Visit Dr. Palese's Wikipedia page
Video
Watch a video featuring the Microbiology and Virology Ph.D. Graduate School Program.
Language
Position
Research Topics
Antivirals, Apoptosis/Cell Death, Biodefense, Coronavirus, Influenza Virus, Interferon, Interferon Antagonists, Nipah Virus, Paramyxovirus, RNA, SARS Virus, Vaccine Development, Virulence Genes, Viruses and Virology
Multi-Disciplinary Training Areas
Disease Mechanisms and Therapeutics (DMT), Microbiology [MIC]
Video
Education
PhD, University of Vienna
Awards
2015
Beijerinck Virology Prize
Royal Netherlands Academy of Arts and Sciences
2014
Elected Fellow of the American Academy of Arts and Sciences
2014
Honorary Doctorate
Baylor College of Medicine
2012
Sanofi–Institut Pasteur Award
2012
Election to the Institute of Medicine of the National Academy of Sciences
2010
European Virology Award (EVA)
European Society for Virology
2006
Elected Member
The German Academy of Sciences Leopoldina
2006
Robert Koch Prize
Berlin
2002
Corresponding Member
Austrian Academy of Sciences
2000
Member
National Academy of Sciences
Research
The Palese Laboratory is interested in training students and postdoctoral fellows who will become independent investigators in "molecular" studies of infectious viral diseases.
Locations
Publications
Selected Publications
- A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern. Victoria Dolange, Stefan Slamanig, Adam Abdeljawad, Tsoi Ying Lai, Nicholas Lemus, Gagandeep Singh, Juan Manuel Carreño, Anass Abbad, Komal Srivastava, Viviana Simon, Jaiprasath Sachithanandham, Andrew Pekosz, David Sullivan, Florian Krammer, Weina Sun, Peter Palese, Irene González-Domínguez. Journal of Infectious Diseases
- Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in Brazil. Érique José Farias Peixoto de Miranda, Rodrigo T. Calado, Fernanda Castro Boulos, José Alfredo de Sousa Moreira, Fabiane Fernandes Machado, Maria Aparecida Alves Leite Dos Santos Almeida, Marcia Cristina Oliveira Da Rocha, Vanessa Infante, Laina D. Mercer, Richard Hjorth, Rami Scharf, Jessica White, Christina Polyak, Rama Raghunandan, Adolfo García-Sastre, Weina Sun, Peter Palese, Florian Krammer, Bruce Innis, Cristiano Gonçalves Pereira, Esper Georges Kallas. Vaccine
- Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models. Irene González-Domínguez, Adam Abdeljawad, Tsoi Ying Lai, Marta Boza, Stephen McCroskery, Nicholas Lemus, Stefan Slamanig, Gagandeep Singh, Prajakta Warang, Temima Yellin, Anass Abbad, Juan Manuel Carreño, Victoria Dolange, Jose Luis Martínez-Guevara, Marina Barcena-Varela, Lauren A. Chang, Michael Schotsaert, Florian Krammer, Peter Palese, Weina Sun. Frontiers in Immunology